AI
RDY icon

Axiom Investors’s Dr. Reddy's Laboratories RDY Stock Holding History

Axiom Investors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-86,600
Closed -$1.37M – 156
2024
Q4 		$1.37M Sell
86,600
-29,000
-25% -$436K 0.01% 127
2024
Q3 		$1.84M Buy
+115,600
New +$1.86M 0.02% 116
2021
Q1 		– Sell
-961,700
Closed -$13.7M – 145
2020
Q4 		$13.7M Buy
961,700
+33,400
+4% +$450K 0.22% 64
2020
Q3 		$12.9M Buy
928,300
+325,950
+54% +$3.88M 0.21% 54
2020
Q2 		$6.39M Buy
602,350
+162,000
+37% +$1.65M 0.13% 63
2020
Q1 		$3.55M Buy
+440,350
New +$3.67M 0.09% 74
2017
Q2 		– Sell
-1,379,500
Closed -$11.1M – 157
2017
Q1 		$11.1M Buy
1,379,500
+117,500
+9% +$1.01M 0.28% 57
2016
Q4 		$11.4M Buy
1,262,000
+107,500
+9% +$1M 0.33% 55
2016
Q3 		$10.7M Buy
1,154,500
+21,575
+2% +$206K 0.3% 53
2016
Q2 		$11.6M Buy
1,132,925
+430,425
+61% +$3.94M 0.34% 55
2016
Q1 		$6.35M Sell
702,500
-3,500
-0.5% -$31.3K 0.2% 56
2015
Q4 		$6.54M Sell
706,000
-219,750
-24% -$2.41M 0.21% 59
2015
Q3 		$11.8M Buy
925,750
+205,250
+28% +$2.55M 0.37% 56
2015
Q2 		$7.97M Buy
720,500
+276,000
+62% +$3.05M 0.23% 59
2015
Q1 		$5.08M Buy
444,500
+100,000
+29% +$1.06M 0.14% 75
2014
Q4 		$3.48M Buy
344,500
+102,250
+42% +$1.08M 0.09% 82
2014
Q3 		$2.55M Buy
+242,250
New +$2.28M 0.06% 100
2014
Q2 		– Sell
-300,500
Closed -$2.64M – 157
2014
Q1 		$2.64M Buy
+300,500
New +$2.61M 0.06% 97

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Axiom Investors's RDY Position: Q1 2025 in Review

Axiom Investors sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 86,600 shares — an estimated $1.37M sold.

Axiom Investors first reported a position in RDY in Q1 2014 and held it in 18 quarters. The position peaked at $13.7M in Q4 2020. 246 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • Axiom Investors reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
  • Axiom Investors sold 86,600 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $1.37M.
  • Axiom Investors first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 18 quarters.
  • Axiom Investors's Dr. Reddy's Laboratories position peaked at $13.7M in Q4 2020.
  • 246 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Axiom Investors's 13F filing for Q1 2025, filed 14 May 2025.